{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:24:26Z","timestamp":1793121866448,"version":"4.5.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Rare diseases (RDs) create a massive burden for governments and families because sufferers of these diseases are required to undergo long-term treatment or rehabilitation to maintain a normal life. In Saudi Arabia (SA), the prevalence of RDs is high as a result of cultural and socio-economic factors. This study, however, aims to shed light on the genetic component of the prevalence of RDs in SA.<\/jats:p><jats:p><jats:bold>Methodology:<\/jats:bold> A retrospective study was conducted between September 2020 and December 2021\u00a0at King Saud Medical City, a tertiary hospital of the Ministry of Health (MOH), SA. A total of 1080 individuals with 544 potentially relevant variants were included. The index was 738, and the samples were tested in a commercialized laboratory using different molecular techniques, including next-generation sequencing.<\/jats:p><jats:p><jats:bold>Result:<\/jats:bold> A total of 867 molecular genetics tests were conducted on 738 probands. These tests included 610 exome sequencing (ES) tests, four genome sequencing (GS) tests, 82 molecular panels, 106 single nucleotide polymorphism (SNP) array, four methylation studies, 58 single-gene studies and three mitochondrial genome sequencing tests. The diagnostic yield among molecular genetics studies was 41.8% in ES, 24% in panels, 12% in SNP array and 24% in single gene studies. The majority of the identified potential variants (68%) were single nucleotide variants (SNV). Other ascertained variants included frameshift (11%), deletion (10%), duplication (5%), splicing (9%), in-frame deletion (3%) and indels (1%). The rate of positive consanguinity was 56%, and the autosomal recessive accounted for 54%. We found a significant correlation between the ES detection rate and positive consanguinity. We illustrated the presence of rare treatable conditions in <jats:italic>DNAJC12<\/jats:italic>, <jats:italic>SLC19A3<\/jats:italic>, and <jats:italic>ALDH7A1,<\/jats:italic> and the presence of the founder effect variant in <jats:italic>SKIC2.<\/jats:italic> Neurodevelopmental disorders were the main phenotype for which genetics studies were required (35.7%).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This is the sixth-largest local study reporting next-generation sequencing. The results indicate the influence of consanguineous marriages on genetic disease and the burden it causes for the Kingdom of SA. This study highlights the need to enrich our society\u2019s knowledge of genetic disorders. We recommend utilising ES as a first-tier test to establish genetic diagnosis in a highly consanguineous population.<\/jats:p>","DOI":"10.3389\/fgene.2023.1243518","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:45:26Z","timestamp":1695285926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Prospect of genetic disorders in Saudi Arabia"],"prefix":"10.3389","volume":"14","author":[{"given":"Amerh S.","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raniah S.","family":"Alotibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghrid","family":"Aloraini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Almsned","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Alassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alfares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alhaddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam M.","family":"Al Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12882-020-02013-2","article-title":"Clinical and genetic characteristics of autosomal recessive polycystic kidney disease in Oman","volume":"21","author":"Al Alawi","year":"2020","journal-title":"BMC Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5144\/0256-4947.2022.29","article-title":"Common disease-associated gene variants in a Saudi Arabian population","volume":"42","author":"Aleissa","year":"2022","journal-title":"Ann. Saudi Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ymgme.2017.04.002","article-title":"A multicenter clinical exome study in unselected cohorts from a consanguineous population of Saudi Arabia demonstrated a high diagnostic yield","volume":"121","author":"Alfares","year":"2017","journal-title":"Mol. Genet. Metabolism"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/gim.2018.41","article-title":"Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing","volume":"20","author":"Alfares","year":"2018","journal-title":"Genet. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12920-020-00743-8","article-title":"What is the right sequencing approach? Solo VS extended family analysis in consanguineous populations","volume":"13","author":"Alfares","year":"2020","journal-title":"BMC Med. Genomics"},{"key":"B6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/01616412.2016.1263176","article-title":"Biotin\u2013thiamine\u2013responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment","volume":"39","author":"Algahtani","year":"2017","journal-title":"Neurological Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/ajmg.a.62491","article-title":"The rate of secondary genomic findings in the Saudi population","volume":"188","author":"Aloraini","year":"2022","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B8","first-page":"1133789","article-title":"The diagnostic yield of CGH and WES in neurodevelopmental disorders","volume-title":"Front. Pediatr.","author":"Alotibi","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ajmg.a.61126","article-title":"Clinical exome sequencing in 509 middle eastern families with suspected mendelian diseases: the Qatari experience","volume":"179","author":"Al\u2010Dewik","year":"2019","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ajhg.2017.01.002","article-title":"Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability","volume":"100","author":"Anikster","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/ajmg.a.37684","article-title":"Syndrome disintegration: exome sequencing reveals that fitzsimmons syndrome is a co\u2010occurrence of multiple events","volume":"170","author":"Armour","year":"2016","journal-title":"Am. J. Med. Genet. Part A"},{"key":"B12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41431-020-00713-9","article-title":"Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort","volume":"29","author":"Bertoli-Avella","year":"2021","journal-title":"Eur. J. Hum. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/s41436-021-01159-0","article-title":"Combining exome\/genome sequencing with data repository analysis reveals novel gene\u2013disease associations for a wide range of genetic disorders","volume":"23","author":"Bertoli-Avella","year":"2021","journal-title":"Genet. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1073\/pnas.0906079106","article-title":"Evolution in health and medicine Sackler colloquium: consanguinity, human evolution, and complex diseases","volume":"107","author":"Bittles","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41525-018-0053-8","article-title":"Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases","volume":"3","author":"Clark","year":"2018","journal-title":"npj Genomic Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.gene.2016.07.021","article-title":"Next-generation sequencing for molecular diagnosis of autosomal recessive polycystic kidney disease","volume":"591","author":"Edrees","year":"2016","journal-title":"Gene"},{"key":"B17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.24911\/jbcgenetics\/183-1614266028","article-title":"Genetic carrier screening for disorders included in newborn screening in the Saudi population","volume":"4","author":"Eissa","year":"2021","journal-title":"J. Biochem. Clin. Genet."},{"key":"B18","first-page":"1","volume-title":"The genome aggregation database (gnomAD)","author":"Karczewski","year":"2017"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","article-title":"VarSome: the human genomic variant search engine","volume":"35","author":"Kopanos","year":"2019","journal-title":"Bioinformatics"},{"key":"B43","doi-asserted-by":"crossref","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1001\/jama.2014.14604","article-title":"Clinical exome sequencing for genetic identification of rare Mendelian disorders","volume":"312","author":"Lee","year":"2014","journal-title":"Jama"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.gim.2022.04.006","article-title":"ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of medical genetics and genomics (ACMG)","volume":"24","author":"Miller","year":"2022","journal-title":"Genet. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: A policy statement of the American College of medical genetics and genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00439-017-1821-8","article-title":"The landscape of genetic diseases in Saudi Arabia based on the first 1000 diagnostic panels and exomes","volume":"136","author":"Monies","year":"2017","journal-title":"Hum. Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.ajhg.2019.04.011","article-title":"Lessons learned from large-scale, first-tier clinical exome sequencing in a highly consanguineous population","volume":"104","author":"Monies","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12881-015-0261-3","article-title":"Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease","volume":"16","author":"Obeidova","year":"2015","journal-title":"BMC Med. Genet."},{"key":"B25","unstructured":"geneMap2023"},{"key":"B26","unstructured":"Orphanet2023"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1534\/genetics.117.300137","article-title":"Pyridoxine-dependent epilepsy in zebrafish caused by Aldh7a1 deficiency","volume":"207","author":"Pena","year":"2017","journal-title":"Genetics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/8904_2012_210","article-title":"Long-term follow-up of a successfully treated case of congenital pyridoxine-dependent epilepsy","volume":"10","author":"Proudfoot","year":"2013","journal-title":"JIMD Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/gim.2015.148","article-title":"Clinical application of whole-exome sequencing across clinical indications","volume":"18","author":"Retterer","year":"2016","journal-title":"Genet. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med. official J. Am. Coll. Med. Genet."},{"key":"B31","unstructured":"Premarital screening2020"},{"key":"B32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cge.12654","article-title":"Utility of whole\u2010exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care","volume":"89","author":"Sawyer","year":"2016","journal-title":"Clin. Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"674295","DOI":"10.3389\/fgene.2021.674295","article-title":"Strategies to uplift novel mendelian gene discovery for improved clinical outcomes","volume":"12","author":"Seaby","year":"2021","journal-title":"Front. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41436-018-0024-6","article-title":"Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: A scoping Review of the literature","volume":"21","author":"Smith","year":"2019","journal-title":"Genet. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ana.25048","article-title":"DNAJC12 and dopa\u2010responsive nonprogressive parkinsonism","volume":"82","author":"Straniero","year":"2017","journal-title":"Ann. neurology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13073-021-00855-5","article-title":"Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients","volume":"13","author":"Stranneheim","year":"2021","journal-title":"Genome Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ejhg.2016.146","article-title":"Clinical exome sequencing: results from 2819 samples reflecting 1000 families","volume":"25","author":"Trujillano","year":"2017","journal-title":"Eur. J. Hum. Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/jmedgenet-2017-104875","article-title":"Heterogeneous clinical spectrum of DNAJC12-deficient hyperphenylalaninemia: from attention deficit to severe dystonia and intellectual disability","volume":"55","author":"van Spronsen","year":"2018","journal-title":"J. Med. Genet."},{"key":"B39","unstructured":"Rare diseases\n            Who\n          2023"},{"key":"B40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrg.2017.116","article-title":"Paediatric genomics: diagnosing rare disease in children","volume":"19","author":"Wright","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1001\/jama.2014.14601","article-title":"Molecular findings among patients referred for clinical whole-exome sequencing","volume":"312","author":"Yang","year":"2014","journal-title":"JAMA - J. Am. Med. Assoc."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1243518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:45:30Z","timestamp":1695285930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1243518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":43,"alternative-id":["10.3389\/fgene.2023.1243518"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1243518","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"article-number":"1243518"}}